You are here
Newsletter - January 2015
Web Release | Mumbai (India) - Jan 15th 2015
J A N U A R Y 2 0 1 5
New Year. Fresh Start. More Options.
Founded in 2004, Neural IT is an ISO 27001 Certified and HIPAA-compliant outsourcing services provider. Our services are aimed at offering reliable medical record review solutions for a diverse spectrum of clients, including law firms, medical-legal consultants, independent medical examiners and physicians.
In other words, we offer law firms options to help them save time reviewing medical records concerning cases involving mass torts, personal injury or workers' compensation.
At Neural IT, we not only consider ourselves as a fine provider of excellent services, but we also aim to go above and beyond of what we can offer. As such, we are beginning the New Year with a monthly newsletter containing recent developments in the legal world of mass torts, personal injury or workers' compensation.
Transvaginal Mesh Litigation
Boston Scientific Corp. (henceforth "Defendant"), a developer & manufacturer of medical devices, in November 2014 was ordered to pay four women over $26 million after a Miami federal court jury found that it was liable for marketing faulty Transvaginal mesh devices.
According to Thompson Reuters, the Plaintiffs sustained bleeding, pain and infection as a result of the company's Pinnacle device, which was developed to treat pelvic organ prolapse and stress urinary incontinence. Although Defendant was ordered to pay $26.7 million in compensatory damages, it will not face additional punitive damages. Each Plaintiff in the case is receiving between $6.5 million and $6.7 million.
Defendant is currently facing over 14,000 federal lawsuits over its mesh devices.
In the last 3 months, Neural IT's Voice Processing division has been highly successful in converting leads for clients. Out of 1,361 possible contacts, the Voice Processing team was able to convert 30.5%, or 416 contacts.
In the Transvaginal Mesh litigation space, Neural IT has had 1,630 medical record requests from firms, out of which 860 were reviewed for evidence. Of those records, our physicians found evidence in 453 that identified the product used in a given case, for a conversation rate of 52.67%.
Neural IT will be attending & exhibiting at the National Trial Lawyers Summit (NTLS) on January 19-21, 2015, at The Loews Miami Beach Hotel, Florida, Booth # 42. If you will be attending, feel free to stop by our booth for additional information.